Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses

Fernando Moreira Simabuco1, Rodrigo Esaki Tamura2, Isadora Carolina Betim Pavan1,3

  • 1Universidade Estadual de Campinas, Faculdade de Ciências Aplicadas (FCA), Laboratório Multidisciplinar em Alimentos e Saúde (LABMAS), Limeira, SP, Brazil.

Insights

This review details the cellular mechanisms of human coronavirus replication, focusing on the SARS-CoV-2 replication transcription complex and host-pathogen interactions. It also explores current pharmacological interventions for COVID-19, aiding future research.

Area of Science:

  • Virology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Coronaviruses, including SARS-CoV-2, SARS-CoV, and MERS-CoV, are significant human pathogens.
  • COVID-19, caused by SARS-CoV-2, presents with symptoms like cough, fever, and pneumonia, impacting millions globally.
  • Understanding coronavirus replication is crucial for developing effective treatments.

Purpose of the Study:

  • To review the cellular mechanisms of human coronavirus replication.
  • To elucidate the molecular events of the coronavirus replication transcription complex (RTC).
  • To examine viral protein and host cell protein interactions and their implications.
  • To discuss current pharmacological interventions targeting COVID-19.

Main Methods:

  • Literature review of cellular mechanisms in coronavirus replication.
  • Analysis of viral protein-host interactions.
  • Review of pharmacological interventions and their molecular targets.

Main Results:

  • Detailed overview of the unique molecular events within the coronavirus RTC.
  • Identification of key host-pathogen interactions influencing coronavirus biology.
  • Summary of current drug development strategies and their mechanisms of action against SARS-CoV-2.

Conclusions:

  • A comprehensive understanding of SARS-CoV-2 replication is essential for developing targeted therapies.
  • Further research into viral replication and host interactions can guide the development of novel antiviral drugs.
  • This review provides a foundation for future studies on COVID-19 pathogenesis and treatment.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
451
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.6K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
832
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.1K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.1K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
460